LIVE at the 2025 AMR Symposium: NCCID CAN AMS with Harpa Isfeld-Kiely

Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Dr. Kanchana Amuratunga to discuss The Public Health Agency of Canada’s AMR Task Force and the Pan Canadian Action Plan. For more information visit:Canada’s AMR Task Force an Introduction to Canada’s Amr Advisory GroupPan-Canadian Action Plan on Antimicrobial Resistance - Canada.caIDSA All Practice Guidelines: A-Z ListFirstline - Antimicrobial Stewardship Mobile App

For this episode we go LIVE from The Quay in Toronto at the 2025 AMR Symposium. "Canadian Sepsis Strategies; Optimizing Patient Management with AMS and Equity"Dr. Rupeena Purewal discusses the National Sepsis Action Plan with Dr. Kali Barrett and Ms. Fatima Sheikh, Ph.D.(c). (Sepsis Canada)

Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Dr. Peter Daley to discuss Canbuild AMR in Newfoundland. For more information visit:Canbuild AMR Audit and Feedback

Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Harpa Isfeld-Kiely from the NCCID to promote CAN AMS and other NCCID initiatives. For more information visit:National Collaborating Centre for Infectious Diseases – Centre de collaboration nationale des maladies infectieusesCAN AMS! – National Collaborating Centre for Infectious DiseasesAMR – Building AMR awareness togetherAMR: Combat Antimicrobial Resistance

Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome cystic fibrosis patient and advocate Huda Razzak from Montreal to discuss antimicrobial resistance in cystic fibrosis. For more information visit:We’re changing the cystic fibrosis story.Home - Do Bugs Need Drugs

Dr. Rupeena Purewal is LIVE at the 2025 AMR Symposium in Toronto visiting with all of you! For this LIVE episode we welcome Jason Vanstone of Saskatchewan to discuss his projects in AMR research and antimicrobial utilization. For more information, contact Jason at:[email protected] Stewardship Program - About Us | SaskHealthAuthority

Dr. Rupeena Purewal welcomes back Dr. George Zhanel, Medical Microbiologist in Winnipeg and Research Director for CARA, to expand on The CLEAR Registry and spotlight clear results for IV Amoxicillin Clavulanate.To join CLEAR, email Dr. Zhanel at [email protected] www.can-r.comCanadian IV AmoxClav Product Monograph: 00074544.PDFCanadian collaborative AMR Awareness campaign: www.antibioticawareness.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html

Dr. Rupeena Purewal welcomes Sepsis expert Dr. Alison Fox-Robichaud to discuss the Canadian challenges and initiatives in Sepsis diagnosis and with Sepsis survivors.Sepsis CanadaCanadian Sepsis FoundationCritical Care Canada

Dr. Rupeena Purewal welcomes Pharmacist Dr. Rosanne Thalakada and Dr. Shaqil Peermohamed to discuss the results of the 5 Point Audit through the ASPIRES Group.ASPIRES - HomeFirstline - Clinical Decision Support PlatformPlanetary Health

Dr. Rupeena Purewal is LIVE* at the 2024 AMR Symposium in Toronto, ON and invites Dr. Bradley Langford, Antimicrobial Stewardship and Antimicrobial Resistance Pharmacist Specialist, Infectious Diseases Pharmacist and Assistant Professor, University of Toronto – NCCID, to introduce AMR Aware Canada and their website www.AMRAware.caThis website is in collaboration with the National Collaborating Center for Infectious Diseases (NCCID) Antimicrobial Resistance (AMR) awareness campaign. NCCID: www.nccid.caCanadian collaborative AMR Awareness campaign: www.antibioticawareness.caPan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html*This episode was recorded in a live session November 20th 2024.